Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.
Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...
Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback